Literature DB >> 29030870

The competitive nature of signal transducer and activator of transcription complex formation drives phenotype switching of T cells.

Ildar I Sadreev1, Michael Z Q Chen2, Yoshinori Umezawa3, Vadim N Biktashev1, Claudia Kemper4,5,6, Diana V Salakhieva7, Gavin I Welsh8, Nikolay V Kotov9.   

Abstract

Signal transducers and activators of transcription (STATs) are key molecular determinants of T-cell fate and effector function. Several inflammatory diseases are characterized by an altered balance of T-cell phenotypes and cytokine secretion. STATs, therefore, represent viable therapeutic targets in numerous pathologies. However, the underlying mechanisms by which the same STAT proteins regulate both the development of different T-cell phenotypes and their plasticity during changes in extracellular conditions remain unclear. In this study, we investigated the STAT-mediated regulation of T-cell phenotype formation and plasticity using mathematical modelling and experimental data for intracellular STAT signalling proteins. The close fit of our model predictions to the experimental data allows us to propose a potential mechanism for T-cell switching. According to this mechanism, T-cell phenotype switching is the result of the relative redistribution of STAT dimer complexes caused by the extracellular cytokine-dependent STAT competition effects. The developed model predicts that the balance between the intracellular STAT species defines the amount of the produced cytokines and thereby T-cell phenotypes. The model predictions are consistent with the experimentally observed interferon-γ to interleukin-10 switching that regulates human T helper type 1/type 1 regulatory T-cell responses. The proposed model is applicable to a number of STAT signalling circuits.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  T cells; interferon-γ; interleukin-10; phenotype switching; signal transducers and activators of transcription

Mesh:

Substances:

Year:  2017        PMID: 29030870      PMCID: PMC5838427          DOI: 10.1111/imm.12851

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  68 in total

1.  IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells.

Authors:  Mari Strengell; Sampsa Matikainen; Jukka Sirén; Anne Lehtonen; Don Foster; Ilkka Julkunen; Timo Sareneva
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

2.  Constitutive tyrosine and serine phosphorylation of STAT4 in T-cells transformed with HTLV-I.

Authors:  Takehiro Higashi; Junichi Tsukada; Yasuhiro Yoshida; Takamitsu Mizobe; Fumihiko Mouri; Yasuhiro Minami; Hiroaki Morimoto; Yoshiya Tanaka
Journal:  Genes Cells       Date:  2005-12       Impact factor: 1.891

3.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

Authors:  K W Moore; P Vieira; D F Fiorentino; M L Trounstine; T A Khan; T R Mosmann
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

4.  Recruitment of Stat1 to chromatin is required for interferon-induced serine phosphorylation of Stat1 transactivation domain.

Authors:  Iwona Sadzak; Melanie Schiff; Irene Gattermeier; Reingard Glinitzer; Ines Sauer; Armin Saalmüller; Edward Yang; Barbara Schaljo; Pavel Kovarik
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-23       Impact factor: 11.205

5.  In vivo pro- and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis.

Authors:  Suppiah Paramalingam Sivalingam; Julian Thumboo; Sheila Vasoo; Szu Tien Thio; Connie Tse; Kok Yong Fong
Journal:  Ann Acad Med Singapore       Date:  2007-02       Impact factor: 2.473

6.  Control mechanism of JAK/STAT signal transduction pathway.

Authors:  Satoshi Yamada; Satoru Shiono; Akiko Joo; Akihiko Yoshimura
Journal:  FEBS Lett       Date:  2003-01-16       Impact factor: 4.124

7.  Abnormal production of pro- and anti-inflammatory cytokines by lupus monocytes in response to apoptotic cells.

Authors:  Sangeeta Sule; Antony Rosen; Michelle Petri; Ehtisham Akhter; Felipe Andrade
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

Review 8.  A chemical biology approach to developing STAT inhibitors: molecular strategies for accelerating clinical translation.

Authors:  Erik A Nelson; Sreenath V Sharma; Jeffrey Settleman; David A Frank
Journal:  Oncotarget       Date:  2011-06

9.  Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose.

Authors:  Margarida Saraiva; Jillian R Christensen; Marc Veldhoen; Theresa L Murphy; Kenneth M Murphy; Anne O'Garra
Journal:  Immunity       Date:  2009-07-30       Impact factor: 31.745

10.  CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis.

Authors:  Charles F Anderson; Mohammed Oukka; Vijay J Kuchroo; David Sacks
Journal:  J Exp Med       Date:  2007-02-05       Impact factor: 14.307

View more
  5 in total

1.  A Functionally Different Immune Phenotype in Cattle Is Associated With Higher Mastitis Incidence.

Authors:  Karina Lutterberg; Kristina J H Kleinwort; Bernhard F Hobmaier; Stefanie M Hauck; Stefan Nüske; Armin M Scholz; Cornelia A Deeg
Journal:  Front Immunol       Date:  2018-12-06       Impact factor: 7.561

Review 2.  Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy.

Authors:  Grégory Verdeil; Toby Lawrence; Anne-Marie Schmitt-Verhulst; Nathalie Auphan-Anezin
Journal:  Cancers (Basel)       Date:  2019-11-21       Impact factor: 6.639

Review 3.  Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins.

Authors:  Adriana Gutiérrez-Hoya; Isabel Soto-Cruz
Journal:  Cells       Date:  2020-10-15       Impact factor: 6.600

4.  Interplay between SMAD2 and STAT5A is a critical determinant of IL-17A/IL-17F differential expression.

Authors:  Karla Fabiola Corral-Jara; Camille Chauvin; Wassim Abou-Jaoudé; Maximilien Grandclaudon; Aurélien Naldi; Vassili Soumelis; Denis Thieffry
Journal:  Mol Biomed       Date:  2021-04-01

Review 5.  Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype.

Authors:  Laura Faletti; Stephan Ehl; Maximilian Heeg
Journal:  Biomed J       Date:  2021-03-20       Impact factor: 4.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.